ArticleFrontiers in cardiovascular medicine2026
Effect of obstructive sleep apnea-hypopnea syndrome on myocardial mechanics in obese patients.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Obesity and obstructive sleep apnea-hypopnea syndrome (OSAHS) often coexist. Chronic intermittent hypoxia in OSAHS can compound cardiac remodeling, but the comprehensive impact of OSAHS severity on obese patients remains unclear. Methods: A total of 83 obese patients were included in this study and divided into the obesity-only group (27 cases) and the obesity-OSAHS group (56 cases) based on the presence of OSAHS. An additional 30 healthy individuals served as the control group. According to the apnea-hypopnea index (AHI), the obesity-OSAHS group was further classified into a mild group (30 cases), moderate group (16 cases), and severe group (10 cases). Echocardiographic and strain parameters were compared across these groups, and factors influencing global longitudinal strain (GLS) were analyzed. Results: Left ventricular GLS progressively declined across the control group (-21.28%), obesity-only group (-18.85%), and obesity-OSAHS group (-17.03%) (all P<0.05). Within the OSAHS group, GLS decreased with increasing severity: mild (-18.00%), moderate (-16.69%), and severe (-14.69%) (all Conclusion: Obese patients exhibit impaired myocardial mechanics, which is further aggravated by OSAHS. With increasing OSAHS severity, GLS declines and myocardial dysfunction worsens. AHI and LVMI are independent risk factors for this dysfunction in obese patients with OSAHS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.